NEVVI Medicare utilization intelligence
or

← back

Provider profile

ZHAO, MENG M.D.

Hematology-Oncology · NPI 1083848337 · EVERETT, WA

1
Groups
20
Codes · 2024
2,294
Disclosed services

ZHAO, MENG is a Hematology-Oncology in EVERETT, WA, a member of 1 medical group, who billed 20 distinct codes to Medicare Part B in 2024.

Groups: SWEDISH HEALTH SERVICES (SEATTLE, WA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

2,294
disclosed services
20
codes billed to Medicare Part B
Prior year · CY2023 40,545 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
82784 Gammaglobulin (immune system protein) measurement
96413 Administration of chemotherapy into vein, 1 hour or less
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96372 Injection of drug or substance under skin or into muscle
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
83540 Iron level
84466 Transferrin (iron binding protein) level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.